Semi‐Synthesis and Biological Evaluation of Phyllanthin Derivatives as Potential Neuroprotective Agents
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Bylapudi Lalitha Kumari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, Balanagar, India. Hauptthemen laut MEDLINE: Neuroprotective Agents, Lignans, Phyllanthus. Die Arbeit nennt 87 Literaturangaben. Gefördert von: This study is supported by the New Faculty Seed Grant (NFSG/PIL/2024/P3862) from the Institute BITS Pilani, Pilani campus..
Abstract (Originalsprache)
Oxidative stress is responsible for the functional loss and sensory impairment of neurons, which leads to progressive loss of brain and spinal cord cells and contributes significantly to several neurological disorders, thus eventually resulting in brain atrophy and death. This study involves the isolation of lignans, including phyllanthin, hypophyllanthin, and nirtetraline, from Phyllanthus amarus . Furthermore, the phyllanhtin was semi‐synthetically modified to give phyllanthin oxadiazole derivatives and was evaluated for neuroprotective activity in scopolamine‐injured neuroblastoma‐2a (N2A) cells. The biochemical assay for reactive oxygen generation (ROS) production in N2A cells was carried out using 2′,7′‐dichlorodihydrofluorescein diacetate (DCFDA) dye, and the mitochondrial membrane potential (MMP) was determined in N2A cells by using JC‐1 dye. Furthermore, the N2A neuronal deaths were evaluated using acridine orange (AO), ethidium bromide (EtBr), and propidium iodide dyes. Among them, nirtetraline, hypophyllanthin, phyllanthin, and compounds 21 and 31 showed potential neuroprotective effects in N2A cells against scopolamine‐induced neurotoxicity by inhibiting ROS production and improving MMP. Moreover, the synthesized compounds were nontoxic to the N2A cell line. Furthermore, in silico docking studies predicted phyllanthin derivatives 21 and 31 exhibit neuroprotective activity by binding to the human NADPH‐oxidase 5 enzyme. Thus, compounds 21 and 31 can be considered potential neuroprotective leads.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, Balanagar, India.
- Department of Biological Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, Balanagar, India.
- Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, Delhi, India.
- Department of Pharmacy, Vidya Vihar, Birla Institute of Technology and Science Pilani, Pilani campus, Pilani, Rajasthan, India.
Förderung
- This study is supported by the New Faculty Seed Grant (NFSG/PIL/2024/P3862) from the Institute BITS Pilani, Pilani campus.
Zitieren
APA
Kumari, B. L., Kumar, R., Sakharam, K. A., Damare, R., Singh, S. B., & Kumar, G. (2025). Semi‐Synthesis and Biological Evaluation of Phyllanthin Derivatives as Potential Neuroprotective Agents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70115
Vancouver
Kumari BL, Kumar R, Sakharam KA, Damare R, Singh SB, Kumar G. Semi‐Synthesis and Biological Evaluation of Phyllanthin Derivatives as Potential Neuroprotective Agents. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70115
BibTeX
@article{Kumari2025,
author = {Kumari, Bylapudi Lalitha and Kumar, Rahul and Sakharam, Kakade Aditi and Damare, Rutuja and Singh, Shashi Bala and Kumar, Gautam},
title = {Semi‐Synthesis and Biological Evaluation of Phyllanthin Derivatives as Potential Neuroprotective Agents},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70115}
}
EUVIMED